Greenwich LifeSciences (GLSI) Interest Coverage Ratio: History & Chart

Greenwich LifeSciences, Inc.(GLSI)

Biotechnology · Stafford, TX

$16.60-0.31 (-1.83%)

Delayed quote: Oct 6, 2026, 11:59 AM EDT

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.

Stafford, TX

13 employees

greenwichlifesciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Snehal S. Patel

View full financials

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Greenwich LifeSciences, Inc. (GLSI)	$243.66M	N/A	N/A	N/A	N/A
Lifecore Biomedical, Inc. (LFCR)vs ›	$243.81M	0.57x	0.57x	0.57x	0.57x
Galectin Therapeutics Inc. (GALT)vs ›	$243.34M	-2.74x	N/A	N/A	N/A
Invivyd, Inc. (IVVD)vs ›	$244.64M	N/A	N/A	N/A	N/A
Akebia Therapeutics, Inc. (AKBA)vs ›	$240.82M	0.97x	0.97x	0.97x	0.97x
CAMP4 Therapeutics Corporation (CAMP)vs ›	$240.66M	N/A	0.97x	1.45x	67.07x
InflaRx N.V. (IFRX)vs ›	$240.09M	-1280.37x	N/A	N/A	N/A
Q32 Bio Inc. (QTTB)vs ›	$247.93M	15.37x	15.37x	15.37x	15.37x
Century Therapeutics, Inc. (IPSC)vs ›	$248.98M	N/A	N/A	N/A	N/A
High Tide Inc. (HITI)vs ›	$237.25M	-1.08x	0.39x	0.39x	0.20x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Greenwich LifeSciences, Inc. (GLSI)

$243.66M

N/A

Lifecore Biomedical, Inc. (LFCR)vs ›

$243.81M

0.57x

Galectin Therapeutics Inc. (GALT)vs ›

$243.34M